14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $27.14 $31.48 Monday, 15th Apr 2024 AGIO stock ended at $29.26. This is 0.85% less than the trading day before Friday, 12th Apr 2024. During the day the stock fluctuated 3.72% from a day low at $28.73 to a day high of $29.80.
90 days $20.96 $35.48
52 weeks $19.80 $35.48

Historical Agios Pharmaceuticals prices

Date Open High Low Close Volume
2023-11-17 $22.47 $23.00 $21.45 $22.26 407 750
2023-11-16 $22.42 $22.60 $21.87 $22.24 280 117
2023-11-15 $22.19 $23.07 $22.19 $22.47 337 579
2023-11-14 $22.30 $22.76 $22.16 $22.30 676 286
2023-11-13 $20.85 $21.45 $20.40 $21.34 371 832
2023-11-10 $21.41 $22.41 $21.04 $21.14 853 584
2023-11-09 $22.63 $22.63 $21.25 $21.36 534 324
2023-11-08 $23.24 $23.30 $22.34 $22.50 361 963
2023-11-07 $22.50 $23.38 $22.35 $23.24 582 215
2023-11-06 $22.56 $22.94 $22.38 $22.42 605 036
2023-11-03 $21.20 $22.83 $21.20 $22.49 2 227 815
2023-11-02 $21.50 $21.90 $20.86 $21.00 641 637
2023-11-01 $20.90 $21.41 $20.74 $21.30 1 933 747
2023-10-31 $20.35 $21.35 $20.35 $21.01 1 089 095
2023-10-30 $20.27 $20.49 $20.04 $20.39 424 707
2023-10-27 $20.59 $20.88 $19.80 $19.97 497 370
2023-10-26 $20.13 $21.03 $20.09 $20.77 420 107
2023-10-25 $20.76 $20.88 $19.99 $20.18 500 647
2023-10-24 $20.97 $21.31 $20.83 $20.92 745 904
2023-10-23 $21.15 $21.48 $20.80 $20.96 417 201
2023-10-20 $21.43 $21.68 $21.06 $21.38 654 321
2023-10-19 $21.70 $21.75 $21.09 $21.42 813 290
2023-10-18 $22.41 $22.41 $21.74 $21.81 489 051
2023-10-17 $22.98 $23.36 $22.04 $22.64 451 335
2023-10-16 $23.19 $23.49 $22.62 $23.11 627 384
Click to get the best stock tips daily for free!

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph... AGIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT